| Literature DB >> 23758823 |
Roger Chun-Man Ho1, Kwok-Kei Mak, Ren Tao, Yanxia Lu, Jeffrey R Day, Fang Pan.
Abstract
BACKGROUND: Peer review is the major method used by biomedical journals for making the decision of publishing an article. This cross-sectional survey assesses views concerning the review system of biomedical journals among academics globally.Entities:
Mesh:
Year: 2013 PMID: 23758823 PMCID: PMC3685540 DOI: 10.1186/1471-2288-13-74
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Figure 1Selection of universities and profile of participants.
Respondent characteristic by academic background and first language
| | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | | |
| Men | 354 (63.2%) | 380 (73.6%) | 208 (78.8%) | 25.3 | <0.001 | 409 (66.9%) | 533 (73.1%) | 6.1 | 0.01* | 942 (70.3%) |
| Women | 206 (36.8%) | 136 (26.4%) | 56 (21.2%) | | | 202 (33.1%) | 196 (26.9%) | | | 398 (29.7%) |
| | | | | | | | | | | |
| Africa | 2 (14.3%) | 5 (35.7%) | 7 (50%) | 54.8 | <0.001 | 6 (42.9%) | 8 (57.1%) | 416.8 | <0.001** | 14 (1.0%) |
| America (North) | 233 (45.6%) | 201 (39.3%) | 77 (15.1%) | 365 (71.4%) | 146 (28.6%) | 511 (38.1%) | ||||
| America (South) | 4 (20.0%) | 12 (60.0%) | 4 (20.0%) | 0 (0%) | 20 (100%) | 20 (1.5%) | ||||
| Asia (Central/ Middle East) | 15 (20.3%) | 46 (62.2%) | 13 (17.6%) | 5 (6.8%) | 69 (93.2%) | 74 (5.5%) | ||||
| Asia (North/East) | 33 (34.4%) | 36 (37.5%) | 27 (28.1%) | 5 (5.2%) | 91 (94.8%) | 96 (7.2%) | ||||
| Australia and New Zealand | 52 (47.7%) | 42 (38.5%) | 15 (13.8%) | 95 (87.2%) | 14 (12.8%) | 109 (8.1%) | ||||
| Europe | 221 (42.8%) | 174 (33.7%) | 121 (23.4%) | | | 135 (26.2%) | 381 (73.8%) | | | 516 (38.5%) |
| 49.9 ± 11.4 | 52.6 ± 10.4 | 52.2 ± 11.2 | 8.8 | <0.001 | 51.9 ± 11.6 | 50.9 ± 10.6 | 1.5 | 0.1 | 51.4 ± 11.1 | |
| 50 | 50 | 61 | 9.8 | 0.007 | 50 | 50 | 0.6 | 0.5 | 50 | |
| (45 – 55) | (45 – 60) | (50 – 75) | | | (50 – 60) | (50 – 59) | | | (95% CI: 50 – 56) | |
| 20.3 ± 10.6 | 20.3 ± 10.8 | 22.4 ± 11.8 | 3.9 | 0.02 | 21.1 ± 11.6 | 20.4 ± 10.4 | 1.3 | 0.2 | 20.7 ± 11 |
Data are percentage (number). Sum of percentages equal to 100% in each category. “SD” refers to standard deviation. P values are from t test, χ2tests, Mann–Whitney Test and Kruskal-Wallis Test.
Values are numbers and percentages unless stated otherwise.
*p < 0.05; **p < 0.01.
Undesirable experiences with biomedical journal peer review (all respondents, n = 1,340)
| The duration of review period is longer than 6 months. | 815 (60.8) | 374 (27.9) | 151 (11.3) |
| The duration of review is longer than a year. | 1231 (91.9) | 88 (6.6) | 21 (1.6) |
| Encountering personal attacks in reviewers’ comments. | 1078 (80.4) | 235 (17.5) | 27 (2.0) |
| Breach of confidentially of articles’ information by reviewers. | 1200 (89.6) | 126 (9.4) | 14 (1.0) |
| Unauthorised use of articles’ information (e.g. authors’ ideas, data or methods) by reviewers after rejection of articles. | 1149 (85.7) | 174 (13.0) | 17 (1.3) |
| Imposition of unnecessary references by reviewers. | 906 (67.6) | 338 (25.2) | 96 (7.2) |
Items are presented in the order of appearance in the questionnaire.
Percentages sum to 100%.
*Responses on a 5-point Likert Scale: 1, very rare; 2, infrequent; 3, sometimes; 4, frequent; 5, All the time.
Views on biomedical journal peer review (all respondents, n = 1,340)
| | | | |
| Biomedical journal peer review is fair. | 304 (22.7) | 387 (28.9) | 649 (48.4) |
| Biomedical journal peer review is transparent. | 610 (45.5) | 393 (29.3) | 337 (25.1) |
| Biomedical journal peer review is scientific. | 304 (22.) | 399 (29.8) | 637 (47.5) |
| Authors should remain anonymous. | 296 (22.1) | 264 (19.7) | 780 (58.2) |
| Reviewers should remain anonymous. | 271 (20.2) | 204 (15.2) | 865 (64.4) |
| Reviewers are competent in general. | 306 (22.8) | 503 (37.5) | 531 (39.6) |
| | | | |
| Reviewers are not required to declare COI. | 1125 (84.0) | 100 (7.5) | 115 (8.6) |
| The journal review process ensures my article to be free from interference of competitors and people with COI. | 659 (49.2) | 426 (31.8) | 255 (19.0) |
| | | | |
| After receiving an article, the editors should give every article a fair chance by sending to peer review and avoiding personal bias. | 244 (18.2) | 506 (37.8) | 590 (44.0%) |
| After receiving reviewers’ feedbacks, editors should screen for unfair reviewers’ comments. | 285 (21.3) | 446 (33.3) | 609 (45.4) |
| Every biomedical journal should provide an appeal system for authors when their articles are unfairly rejected. | 198 (14.8) | 235 (17.5) | 907 (67.7) |
Items are presented in the order of appearance in the questionnaire.
Percentages sum to 100%.
*Responses on a 5-point Likert Scale: 1, very rare; 2, infrequent; 3, sometimes; 4, frequent; 5, All the time.
Comparison of responses between native and non-native English speaking respondents
| | | | ||||||
|---|---|---|---|---|---|---|---|---|
| | ||||||||
| | | | | | | | | |
| Personal attacks | 512 (83.8) | 93 (15.2) | 6 (1.0) | 566 (77.7) | 142 (19.5) | 21 (2.9) | ||
| Breach of confidentiality | 552 (90.4) | 55 (9.0) | 4 (0.7) | 648 (88.8) | 71 (9.7) | 10 (1.3) | ||
| Unauthorised use of articles’ information after rejection of articles | 528 (86.4) | 75 (12.3) | 8 (1.3) | 621 (85.2) | 99 (13.6) | 9 (1.2) | ||
| Imposition of unnecessary references | 435 (71.2) | 130 (21.3) | 46 (7.5) | 471 (64.6) | 208 (28.5) | 50 (6.8) | | |
| | ||||||||
| | | | ||||||
| | | | | | | | | |
| fair | 122 (19.9) | 169 (27.7) | 320 (52.3) | 182 (25.0) | 218 (29.9) | 329 (45.2) | 7.8 | 0.02* |
| transparent | 276 (45.2) | 172 (28.2) | 163 (26.7) | 334 (45.8) | 221 (30.3) | 174 (23.8) | 1.6 | 0.5 |
| scientific | 158 (25.8) | 184 (30.1) | 269 (44.0) | 146 (20.0) | 215 (29.5) | 368 (50.5) | 7.9 | 0.02* |
| free from interference | 299 (48.9) | 184 (30.1) | 128 (21.0) | 360 (49.4) | 242 (33.2) | 127 (17.5) | 3.2 | 0.2 |
| | | | | | | | | |
| give an article a fair hearing by sending to peer review and avoid personal bias | 109 (17.9) | 207 (33.9) | 295 (48.3) | 135 (18.5) | 299 (41.0) | 295 (40.5) | 9.2 | 0.01* |
| screen for unfair comments | 113 (18.5) | 196 (32.1) | 302 (49.4) | 172 (23.6) | 250 (34.3) | 307 (42.1) | 8.5 | 0.01* |
| | | | | | | | | |
| Anonymity of reviewers | 125 (20.5) | 85 (13.9) | 401 (65.6) | 146 (20.0) | 119 (16.3) | 464 (63.7) | 0.5 | 0.5 |
| Not require to declare conflict of interest | 552 (90.4) | 25 (4.1) | 34 (5.6) | 573 (78.6) | 75 (10.3) | 81 (11.1) | 34.5 | <0.001** |
| Competent in general | 153 (25.1) | 206 (33.7) | 252 (41.2) | 153 (21.0) | 297 (40.7) | 279 (38.3) | 7.5 | 0.02* |
| 144 (23.6) | 119 (19.5) | 348 (56.9) | 152 (20.8) | 145 (19.9) | 432 (59.3) | 1.4 | 0.5 | |
| 98 (16.0) | 90 (14.7) | 423 (69.3) | 100 (13.7) | 145 (19.9) | 484 (66.4) | 6.7 | 0.04* | |
*p < 0.05; **p < 0.01.
Comparison of responses among basic scientists, clinicians and clinician-scientists
| | | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| | ||||||||||
| | | | | | | | | | | |
| 442 (78.9) | 100 (17.9) | 18 (3.2) | 439 (85.1) | 74 (14.3) | 3 (0.6) | 197 (74.6) | 61 (23.1) | 6 (2.3) | 0.001** | |
| 499 (89.1) | 56 (10.0) | 5 (0.9) | 484 (93.8) | 28 (5.4) | 4 (0.8) | 217 (82.2) | 42 (15.9) | 5 (1.9) | <0.001** | |
| 485 (86.6) | 71 (12.7) | 4 (0.7) | 458 (88.8) | 50 (9.7) | 8 (1.6) | 206 (78.0) | 53 (20.1) | 5 (1.9) | 0.001** | |
| 363 (64.8) | 154 (27.5) | 43 (7.7) | 389 (74.5) | 99 (19.2) | 28 (5.4) | 154 (58.3) | 85 (32.2) | 25 (9.5) | <0.001** | |
| | ||||||||||
| | | |||||||||
| | | | | | | | | | | |
| 137 (24.5) | 166 (29.6) | 257 (45.9) | 97 (18.1) | 137 (26.6) | 282 (54.7) | 70 (26.5) | 84 (31.8) | 110 (41.7) | 0.004** | |
| 250 (44.6) | 176 (31.4) | 134 (23.9) | 225 (43.6) | 152 (29.5) | 139 (26.9) | 135 (51.1) | 65 (24.6) | 64 (24.2) | 0.2 | |
| 117 (20.9) | 167 (29.8) | 276 (49.3) | 119 (23.1) | 152 (29.5) | 245 (47.5) | 68 (25.8) | 80 (30.3) | 116 (43.9) | 0.6 | |
| 283 (50.5) | 179 (32.0 | 98 (17.5) | 228 (44.2) | 167 (32.4) | 121 (23.4) | 148 (56.1) | 80 (30.3) | 36 (13.6) | 0.004** | |
| 138 (24.6) | 115 (20.5) | 307 (54.8) | 89 (17.2) | 99 (19.2) | 328 (63.6) | 69 (26.1) | 50 (18.9) | 145 (54.9) | 0.009** | |
| 93 (16.6) | 100 (17.9) | 367 (65.5) | 74 (14.3) | 95 (18.4) | 347 (67.2) | 31 (11.7) | 40 (15.2) | 193 (73.1) | 0.2 | |
*p < 0.05; **p < 0.01.
Figure 2Proportion of frequencies of breach of confidentiality by reviewers encountered by respondents, according to academic background and continent.
Figure 3Proportion of frequencies of unauthorized use of articles’ information (e.g. authors’ idea, data or research methods) by reviewers after rejection of articles, according to academic background and continent.
Figure 4Proportion of frequencies of imposition by reviewers to include unnecessary references according to academic background and continent.
Figure 5Proportion of agreement with peer review being fair by respondents, according to specialty.
Figure 6Proportion of agreement to the establishment of an appeal system within the journal by respondents, according to specialty.
Univariate regression analysis of the association between degree of agreement that biomedical journal peer review is fair and demographics, academic background and frequency of undesirable experiences encountered
| | | | | |
| Age | −0.001 | 0.003 | 0.1 | 0.7 |
| Gender (Female) | −0.1 | 0.05 | 4.9 | 0.03* |
| English as first language | −0.05 | 0.06 | 0.7 | 0.4 |
| | | | | |
| Number of publications | <0.001 | <0.001 | 0.2 | 0.7 |
| Years of experience in biomedical research | 0.001 | 0.003 | 0.07 | 0.8 |
| | | | | |
| Review times longer than one year | −0.03 | 0.04 | 0.9 | 0.4 |
| Personal attacks in reviewers’ comments | −0.1 | 0.03 | 9.9 | 0.002** |
| Breach of confidentiality by reviewers | −0.022 | 0.04 | 0.4 | 0.6 |
| Unauthorised use of articles’ information after rejection of articles | −0.022 | 0.03 | 0.4 | 0.5 |
| Imposition of unnecessary references by reviewers | −0.06 | 0.03 | 4.4 | 0.04* |
*p < 0.05; **p < 0.01.